Skip to main content

Closed

NVS: Novartis AG Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+10.8% / yr

Operating margin29.9%

ROIC13.4%

Financially safe

Strong

Debt / equity1.18×

Interest coverage11.9×

Current ratio0.86×

Valuation

Unrated

P/E ratio23.8×

Dividend yield2.9%

Novartis AG

NVSNew York Stock Exchange·USD·Closed

Novartis AG

NVSNew York Stock Exchange·USD·Closed

$156.15

−1.45%

$156.15

−$2.29 (1.45%)

52W Range

75thpctl

Volume

0.70×avg

Mkt Cap

296.80BUSD

P/E

23.8TTM

Div Yield

2.92%ann

52W Range

75thpctl

Volume

0.70×avg

Market Cap

296.80BUSD

P/E Ratio

23.8TTM

Div Yield

2.92%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings